CompletedNCT02022501
A Phase I/II Safety Study of DE-120 Injectable Solution for Age-related Macular Degeneration
PHASE1 · PHASE2 · 10 planned enrolment
- Countries listed
- 1
- Registry update
- April 18, 2018
immortal.lifeTrial registrations containing the exact intervention label DE-120.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE1 · PHASE2 · 10 planned enrolment
PHASE2 · 16 planned enrolment